PMID- 16126002 OWN - NLM STAT- MEDLINE DCOM- 20051017 LR - 20161126 IS - 0006-3002 (Print) IS - 0006-3002 (Linking) VI - 1736 IP - 2 DP - 2005 Sep 15 TI - Inhibitors of actin polymerisation stimulate arachidonic acid release and 5-lipoxygenase activation by upregulation of Ca2+ mobilisation in polymorphonuclear leukocytes involving Src family kinases. PG - 109-19 AB - Here, we show that actin polymerisation inhibitors such as latrunculin B (LB), and to a minor extent also cytochalasin D (Cyt D), enhance the release of arachidonic acid (AA) as well as nuclear translocation of 5-lipoxygenase (5-LO) and 5-LO product synthesis in human polymorphonuclear leukocytes (PMNL), challenged with thapsigargin (TG) or N-formyl-methionyl-leucyl-phenylalanine. The concentration-dependent effects of LB (EC50 approximately 200 nM) declined with prolonged preincubation (>3 min) prior TG and were barely detectable when PMNL were stimulated with Ca2+-ionophores. Investigation of the stimulatory mechanisms revealed that LB (or Cyt D) elicits Ca2+ mobilisation and potentiates stimulus-induced elevation of intracellular Ca2+, regardless of the nature of the stimulus. LB caused rapid but only moderate activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK)2. The selective Src family kinase inhibitors PP2 and SU6656 blocked LB- or Cyt D-mediated Ca2+ mobilisation and suppressed the upregulatory effects on AA release and 5-LO product synthesis, without affecting AA metabolism evoked by ionophore alone. We conclude that in PMNL, inhibitors of actin polymerisation cause enhancement of intracellular Ca2+ levels through Src family kinase signaling, thereby facilitating stimulus-induced release of AA and 5-LO product formation. FAU - Fischer, Lutz AU - Fischer L AD - Institute of Pharmaceutical Chemistry, University of Frankfurt, Marie-Curie Strasse 9, D-60439 Frankfurt, Germany. FAU - Poeckel, Daniel AU - Poeckel D FAU - Buerkert, Eva AU - Buerkert E FAU - Steinhilber, Dieter AU - Steinhilber D FAU - Werz, Oliver AU - Werz O LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Biochim Biophys Acta JT - Biochimica et biophysica acta JID - 0217513 RN - 0 (Actins) RN - 0 (Bridged Bicyclo Compounds, Heterocyclic) RN - 0 (Nucleic Acid Synthesis Inhibitors) RN - 0 (Polymers) RN - 0 (Thiazoles) RN - 0 (Thiazolidines) RN - 22144-77-0 (Cytochalasin D) RN - 27YG812J1I (Arachidonic Acid) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - 67526-95-8 (Thapsigargin) RN - EC 1.13.11.34 (Arachidonate 5-Lipoxygenase) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - LW7U308U7U (latrunculin B) RN - SY7Q814VUP (Calcium) SB - IM MH - Actins/*metabolism MH - Adult MH - Arachidonate 5-Lipoxygenase/*metabolism MH - Arachidonic Acid/*metabolism MH - Bridged Bicyclo Compounds, Heterocyclic/metabolism/*pharmacology MH - Calcium/*metabolism MH - Cytochalasin D/metabolism/*pharmacology MH - Enzyme Activation MH - Humans MH - Mitogen-Activated Protein Kinases/metabolism MH - N-Formylmethionine Leucyl-Phenylalanine/pharmacology MH - Neutrophils/*drug effects/metabolism MH - Nucleic Acid Synthesis Inhibitors/pharmacology MH - Polymers MH - Thapsigargin/pharmacology MH - Thiazoles/metabolism/*pharmacology MH - Thiazolidines MH - Up-Regulation MH - src-Family Kinases/antagonists & inhibitors/*metabolism EDAT- 2005/08/30 09:00 MHDA- 2005/10/18 09:00 CRDT- 2005/08/30 09:00 PHST- 2005/04/07 00:00 [received] PHST- 2005/07/13 00:00 [revised] PHST- 2005/07/27 00:00 [accepted] PHST- 2005/08/30 09:00 [pubmed] PHST- 2005/10/18 09:00 [medline] PHST- 2005/08/30 09:00 [entrez] AID - S1388-1981(05)00170-8 [pii] AID - 10.1016/j.bbalip.2005.07.006 [doi] PST - ppublish SO - Biochim Biophys Acta. 2005 Sep 15;1736(2):109-19. doi: 10.1016/j.bbalip.2005.07.006.